[{"address1": "170 Harbor Way", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 550 3500", "fax": "650 871 8580", "website": "https://vaxart.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Lo", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 879327, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sean N. Tucker Ph.D.", "age": 56, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 622439, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James F. Cummings M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 679943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeroen  Grasman M.B.A.", "title": "CFO, Principal Accounting Officer & Principal Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raymond D. Stapleton Jr., Ph.D.", "age": 52, "title": "Chief Technology Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward B. Berg", "age": 59, "title": "Senior VP & General Counsel", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laurie  Hastings", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shaily Jaini Garg", "title": "Senior Vice President of Clinical Development & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Kapoor Ph.D.", "title": "Senior Vice President of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://newsroom.biotapharma.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5325, "open": 0.5371, "dayLow": 0.4818, "dayHigh": 0.5394, "regularMarketPreviousClose": 0.5325, "regularMarketOpen": 0.5371, "regularMarketDayLow": 0.4818, "regularMarketDayHigh": 0.5394, "exDividendDate": 1352419200, "payoutRatio": 0.0, "beta": 1.148, "forwardPE": -1.2060976, "volume": 2846301, "regularMarketVolume": 2846301, "averageVolume": 4316030, "averageVolume10days": 5591830, "averageDailyVolume10Day": 5591830, "bid": 0.3722, "ask": 0.6297, "bidSize": 2, "askSize": 2, "marketCap": 121528816, "fiftyTwoWeekLow": 0.28, "fiftyTwoWeekHigh": 1.07, "priceToSalesTrailing12Months": 2.5641696, "fiftyDayAverage": 0.4556, "twoHundredDayAverage": 0.61345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 91479248, "profitMargins": -1.22633, "floatShares": 226926647, "sharesOutstanding": 228223008, "sharesShort": 21173323, "sharesShortPriorMonth": 14348733, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0928, "heldPercentInsiders": 0.01064, "heldPercentInstitutions": 0.120790005, "shortRatio": 2.61, "shortPercentOfFloat": 0.094, "impliedSharesOutstanding": 245760992, "bookValue": 0.2, "priceToBook": 2.4725, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -58122000, "trailingEps": -0.24, "forwardEps": -0.41, "lastSplitFactor": "1:11", "lastSplitDate": 1518566400, "enterpriseToRevenue": 1.93, "enterpriseToEbitda": -1.896, "52WeekChange": -0.28985506, "SandP52WeekChange": 0.12748289, "lastDividendValue": 12.188, "lastDividendDate": 1352419200, "quoteType": "EQUITY", "currentPrice": 0.4945, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.66667, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 41938000, "totalCashPerShare": 0.184, "ebitda": -48238000, "totalDebt": 20561000, "quickRatio": 0.589, "currentRatio": 0.636, "totalRevenue": 47395000, "debtToEquity": 45.072, "revenuePerShare": 0.218, "returnOnAssets": -0.28899, "returnOnEquity": -1.14743, "grossProfits": -38549000, "freeCashflow": 50391000, "operatingCashflow": -33172000, "revenueGrowth": 8.572, "grossMargins": -0.81336, "ebitdaMargins": -1.01779, "operatingMargins": -0.71541, "financialCurrency": "USD", "symbol": "VXRT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Vaxart, Inc.", "corporateActions": [], "postMarketTime": 1751068566, "regularMarketTime": 1751054401, "regularMarketChangePercent": -7.13615, "regularMarketPrice": 0.4945, "exchange": "NCM", "messageBoardId": "finmb_37819645", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "twoHundredDayAverageChangePercent": -0.1939033, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 376929000000, "shortName": "Vaxart, Inc. - Common Stock", "postMarketChangePercent": 0.0, "postMarketPrice": 0.4945, "postMarketChange": 0.0, "regularMarketChange": -0.038, "regularMarketDayRange": "0.4818 - 0.5394", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4316030, "fiftyTwoWeekLowChange": 0.21450001, "fiftyTwoWeekLowChangePercent": 0.76607144, "fiftyTwoWeekRange": "0.28 - 1.07", "fiftyTwoWeekHighChange": -0.5755, "fiftyTwoWeekHighChangePercent": -0.53785044, "fiftyTwoWeekChangePercent": -28.985506, "dividendDate": 1518566400, "earningsTimestamp": 1747166400, "earningsTimestampStart": 1754477940, "earningsTimestampEnd": 1754913600, "earningsCallTimestampStart": 1747168200, "earningsCallTimestampEnd": 1747168200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.24, "epsForward": -0.41, "epsCurrentYear": -0.29, "priceEpsCurrentYear": -1.7051725, "fiftyDayAverageChange": 0.038900018, "fiftyDayAverageChangePercent": 0.085381955, "twoHundredDayAverageChange": -0.11894998, "displayName": "Vaxart", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]